SecBot SecBot
SC 13G ·Filed Nov 12, 2026

XLO

Xilio Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed4d 17h ago SEC0000919574-26-007551
Passive investor 5%+ stake
Actionable Insight • Neutral

Adage Capital is a new significant holder; monitor future 13G amendments for stake changes and any 8-K earnings or pipeline updates that could influence their position. The passive filing suggests no near-term activist engagement.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$8.24
T+0 close · Nov 12, 2026 · via day close
Latest settled
−2.00%
T+1 · $8.08
Vs SPY
−1.64%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $8.24entry
  2. T+1 · 4d ago −2.00%α −1.64% · $8.08
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Adage Capital Management disclosed a 7.06% passive stake in Xilio Therapeutics via a new Schedule 13G, holding 464,598 shares as of September 30, 2026. This is a new filer for Xilio, adding a notable hedge fund investor to the register, though the stake is passive with no control intent.

Key Financial Metrics

Stake
7.06%
Investor
Adage Capital Management, L.P.
Investor Type
hedge fund

Key Facts

  • Adage Capital Management disclosed 464,598 shares of Xilio Therapeutics common stock, representing 7.06% of shares outstanding.
  • Stake is based on 6,580,153 shares outstanding as of August 10, 2026, per the company's Q2 2026 10-Q.
  • Filing is a new Schedule 13G, not an amendment; Adage was not previously a reported 5% holder.
  • Adage certifies passive intent under Rule 13d-1(b), with no purpose of changing or influencing control.
  • Filing date is November 12, 2026, with beneficial ownership as of September 30, 2026.

Financial Impact

7.06% stake valued at approximately $3.95M based on $56M market cap

ownership concentration

Risk Factors

  • Passive 13G status could change to 13D if Adage later engages actively, but no indication in this filing.
  • Micro-cap biotech with $56M market cap; large holder exits could pressure stock.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000919574-26-007551
Document: 0000919574-26-007551-index-headers.html0000919574-26-007551
Document: 0000919574-26-007551-index.html0000919574-26-007551
Document: 0000919574-26-007551.txt0000919574-26-007551

Track record

16 reports on XLO

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +19.92% at T+60 after the May 12, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $7.70 Now $7.70 −0.00% settles Nov 24
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $7.96 Now $7.70 −3.27% settles Nov 23
  3. Nov 12, 20264d ago SC 13G Neutral 4/10 Viewing Entry $8.24 Now $7.70 −6.55% settles Nov 19
  4. Nov 10, 20266d ago Press Release Neutral 4/10 Entry $8.53 Now $7.70 −9.73% settles Nov 17
  5. Oct 26, 202621d ago Press Release Neutral 4/10 Entry $7.31 to $8.03 Now $7.70 +5.34% ▲ +9.85% +11.11% vs SPY
  6. Aug 12, 202613w ago 8-K Bullish 7/10 No price data
  7. Aug 12, 202613w ago Press Release Bullish 7/10 Entry $9.05 to $9.41 Now $7.70 −14.92% ▲ +3.98% +4.42% vs SPY
  8. Jun 1, 202624w ago EFFECT Bearish 5/10 Entry $8.25 to $7.70 Now $7.70 +6.67% ▲ +6.67% +3.92% vs SPY
  9. May 27, 202624w ago S-3/A Neutral 4/10 Entry $8.52 to $8.15 Now $7.70 −9.62% ▼ −4.40% −4.35% vs SPY
  10. May 12, 202626w ago 8-K Neutral 4/10 No price data
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026